首页 > 最新文献

Colorectal Disease最新文献

英文 中文
Methodological considerations regarding long-term performance and interpretation of faecal immunochemical testing 关于粪便免疫化学检测的长期性能和解释的方法学考虑。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-03 DOI: 10.1111/codi.70386
Ting Chen
{"title":"Methodological considerations regarding long-term performance and interpretation of faecal immunochemical testing","authors":"Ting Chen","doi":"10.1111/codi.70386","DOIUrl":"10.1111/codi.70386","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for not achieving stoma self-care proficiency at hospital discharge and development of a clinical prediction model: A study based on the Danish Stoma Database 出院时未达到造口自我护理熟练程度的危险因素及临床预测模型的建立:基于丹麦造口数据库的研究
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-03 DOI: 10.1111/codi.70382
Marianne Krogsgaard, Trine Bolette Borglit, Tobias Wirenfeldt Klausen, Eva Carlsson, Gerd Friis Bille, Bo Marcel Christensen, Ismail Gögenur

Aim

Stoma self-care is critical for long-term adaptation. Personalised approaches may help identify patients needing additional guidance during initial admission. This study aimed to examine factors associated with not achieving stoma self-care proficiency and develop a risk model for use in clinical practice.

Method

We linked prospective health data from the Danish Stoma Database Capital Region and the Danish Anaesthesia Database. Multiple logistic regression analysis provided risk factors associated with not achieving stoma self-care proficiency. The C-statistic was used to evaluate the discriminative ability of logistic regression models. Data were randomly split into training and validation sets to develop models and estimate risk in predefined groups.

Results

Of 5826 pre-determined for ostomy self-care, 4910 (84%) achieved proficiency at discharge, while 916 (16%) did not. Patients of older age, female sex, smokers, higher BMI and ASA scores were more likely not to perform stoma self-care. Significant treatment factors were the type of surgery, surgical approach and ‘stoma not visible to patient’. The risk model included five dichotomous factors: age ≥ 50, age ≥ 70, ASA score ≥ III, acute surgery and female sex. Each risk factor provided a score of 0 or 1 point, resulting in a maximum of five points for high-risk patients. The C-index was 0.66.

Conclusion

Baseline characteristics, treatment factors and stoma visibility were associated with a reduced likelihood of achieving stoma self-care proficiency. The risk model, which incorporates readily known variables, may help clinicians identify patients at risk. The model should be further tested in a clinical setting.

目的:造口自我护理对长期适应至关重要。个性化的方法可能有助于识别在初次入院时需要额外指导的患者。本研究旨在探讨与不能达到造口自我护理水平相关的因素,并建立一个用于临床实践的风险模型。方法:我们将来自丹麦Stoma数据库首都地区和丹麦麻醉数据库的前瞻性健康数据联系起来。多元逻辑回归分析提供了未达到造口自我护理熟练程度的相关危险因素。采用c统计量评价logistic回归模型的判别能力。数据随机分为训练集和验证集,以开发模型并估计预定义组的风险。结果:在5826例预先确定的造口自我护理中,4910例(84%)出院时达到熟练程度,916例(16%)未达到熟练程度。年龄较大、女性、吸烟者、BMI和ASA评分较高的患者更有可能不进行造口自我护理。手术类型、手术入路和“患者不可见造口”是重要的治疗因素。风险模型包括年龄≥50岁、年龄≥70岁、ASA评分≥III、急性手术和女性5个二分类因素。每个危险因素提供0或1分的评分,高危患者最多可得5分。c指数为0.66。结论:基线特征、治疗因素和造口可见性与实现造口自我护理熟练程度的可能性降低有关。风险模型包含了已知的变量,可以帮助临床医生识别有风险的患者。该模型应在临床环境中进一步测试。
{"title":"Risk factors for not achieving stoma self-care proficiency at hospital discharge and development of a clinical prediction model: A study based on the Danish Stoma Database","authors":"Marianne Krogsgaard,&nbsp;Trine Bolette Borglit,&nbsp;Tobias Wirenfeldt Klausen,&nbsp;Eva Carlsson,&nbsp;Gerd Friis Bille,&nbsp;Bo Marcel Christensen,&nbsp;Ismail Gögenur","doi":"10.1111/codi.70382","DOIUrl":"10.1111/codi.70382","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Stoma self-care is critical for long-term adaptation. Personalised approaches may help identify patients needing additional guidance during initial admission. This study aimed to examine factors associated with not achieving stoma self-care proficiency and develop a risk model for use in clinical practice.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>We linked prospective health data from the Danish Stoma Database Capital Region and the Danish Anaesthesia Database. Multiple logistic regression analysis provided risk factors associated with not achieving stoma self-care proficiency. The C-statistic was used to evaluate the discriminative ability of logistic regression models. Data were randomly split into training and validation sets to develop models and estimate risk in predefined groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 5826 pre-determined for ostomy self-care, 4910 (84%) achieved proficiency at discharge, while 916 (16%) did not. Patients of older age, female sex, smokers, higher BMI and ASA scores were more likely not to perform stoma self-care. Significant treatment factors were the type of surgery, surgical approach and ‘stoma not visible to patient’. The risk model included five dichotomous factors: age ≥ 50, age ≥ 70, ASA score ≥ III, acute surgery and female sex. Each risk factor provided a score of 0 or 1 point, resulting in a maximum of five points for high-risk patients. The C-index was 0.66.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Baseline characteristics, treatment factors and stoma visibility were associated with a reduced likelihood of achieving stoma self-care proficiency. The risk model, which incorporates readily known variables, may help clinicians identify patients at risk. The model should be further tested in a clinical setting.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to define the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in T4 colon cancer 是时候确定高温腹腔化疗(HIPEC)在T4结肠癌中的作用了。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-02 DOI: 10.1111/codi.70393
Mina Sarofim

T4 colon adenocarcinoma, defined by tumour penetration of the visceral peritoneum or invasion of adjacent structures, carries a 15%–30% risk of peritoneal metastases (PM) despite curative resection and adjuvant systemic chemotherapy. Hyperthermic intraperitoneal chemotherapy (HIPEC) offers a biologically rational strategy to eradicate occult intraperitoneal tumour cells by exposing the peritoneal cavity to heated cytotoxic agents with enhanced penetration and synergistic thermal cytotoxicity. Although widely used with cytoreductive surgery for established PM, its prophylactic or adjuvant role in non-metastatic T4 disease remains uncertain. Randomized evidence is conflicting and divergent outcomes may be explained by a mechanistic triad encompassing: (1) timing of intraperitoneal drug exposure relative to early tumour implantation and adhesion formation; (2) pharmacological, thermal, and dosing characteristics of the HIPEC regimen, including its most often single administration; and (3) underlying biological heterogeneity within T4 tumours. Thus, HIPEC for T4 colon cancer remains promising in selected patients, and it may be established as routine if ongoing studies rigorously define timing, agent selection and biomarker-driven patient stratification.

T4结肠腺癌的定义是肿瘤穿透内脏腹膜或侵犯邻近结构,尽管进行根治性切除和辅助全身化疗,但仍有15%-30%的腹膜转移(PM)风险。高温腹腔化疗(HIPEC)提供了一种生物学上合理的策略,通过将腹腔暴露于具有增强穿透性和协同热细胞毒性的加热细胞毒性药物中来根除腹腔内隐藏的肿瘤细胞。尽管与细胞减少手术一起广泛用于确诊的PM,但其在非转移性T4疾病中的预防或辅助作用仍不确定。随机证据是相互矛盾的,不同的结果可能由一个机制的三重因素来解释:(1)相对于早期肿瘤植入和粘连形成,腹腔内药物暴露的时间;(2) HIPEC方案的药理学、热学和给药特性,包括其最常见的单次给药;(3) T4肿瘤内潜在的生物学异质性。因此,HIPEC治疗T4结肠癌在特定患者中仍然有希望,如果正在进行的研究严格定义时间、药物选择和生物标志物驱动的患者分层,HIPEC可能会成为常规治疗。
{"title":"Time to define the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in T4 colon cancer","authors":"Mina Sarofim","doi":"10.1111/codi.70393","DOIUrl":"10.1111/codi.70393","url":null,"abstract":"<p>T4 colon adenocarcinoma, defined by tumour penetration of the visceral peritoneum or invasion of adjacent structures, carries a 15%–30% risk of peritoneal metastases (PM) despite curative resection and adjuvant systemic chemotherapy. Hyperthermic intraperitoneal chemotherapy (HIPEC) offers a biologically rational strategy to eradicate occult intraperitoneal tumour cells by exposing the peritoneal cavity to heated cytotoxic agents with enhanced penetration and synergistic thermal cytotoxicity. Although widely used with cytoreductive surgery for established PM, its prophylactic or adjuvant role in non-metastatic T4 disease remains uncertain. Randomized evidence is conflicting and divergent outcomes may be explained by a mechanistic triad encompassing: (1) timing of intraperitoneal drug exposure relative to early tumour implantation and adhesion formation; (2) pharmacological, thermal, and dosing characteristics of the HIPEC regimen, including its most often single administration; and (3) underlying biological heterogeneity within T4 tumours. Thus, HIPEC for T4 colon cancer remains promising in selected patients, and it may be established as routine if ongoing studies rigorously define timing, agent selection and biomarker-driven patient stratification.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146100007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TAMIS procedure for a recurrent rectal lesion at anastomotic site—A video vignette 吻合口复发性直肠病变的TAMIS手术-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-31 DOI: 10.1111/codi.70389
Ejaz Ahmed Latif, Ali Toffaha, Ammar Aleter, Amjad Parvaiz, Mohamed Abu Nada, Mohamed Kurer
{"title":"TAMIS procedure for a recurrent rectal lesion at anastomotic site—A video vignette","authors":"Ejaz Ahmed Latif,&nbsp;Ali Toffaha,&nbsp;Ammar Aleter,&nbsp;Amjad Parvaiz,&nbsp;Mohamed Abu Nada,&nbsp;Mohamed Kurer","doi":"10.1111/codi.70389","DOIUrl":"10.1111/codi.70389","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translating rectopexy practice variability into precision care innovative directions 将直肠矫正术实践的可变性转化为精准护理的创新方向。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-31 DOI: 10.1111/codi.70391
Zejun Song, Yiqi Guo
{"title":"Translating rectopexy practice variability into precision care innovative directions","authors":"Zejun Song,&nbsp;Yiqi Guo","doi":"10.1111/codi.70391","DOIUrl":"10.1111/codi.70391","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When the colon falls short: A technical note on tension-free colorectal anastomosis via duodenal window – A video vignette 当结肠不通畅时:经十二指肠窗无张力结直肠吻合术的技术说明-视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-31 DOI: 10.1111/codi.70384
Pablo Baeza-Ibáñez, Valentina Maluenda-Almonacid
{"title":"When the colon falls short: A technical note on tension-free colorectal anastomosis via duodenal window – A video vignette","authors":"Pablo Baeza-Ibáñez,&nbsp;Valentina Maluenda-Almonacid","doi":"10.1111/codi.70384","DOIUrl":"10.1111/codi.70384","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic utility of bowel ultrasonography in adults with inflammatory bowel disease: An updated systematic review and meta-analysis 肠超声检查在成人炎症性肠病诊断中的应用:一项最新的系统综述和荟萃分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-30 DOI: 10.1111/codi.70370
Hareesha Rishab Bharadwaj, Syed Hasham Ali, Hassam Ali, Priyal Dalal, Aditya Gaur, Sushil Rayamajhi, Arkadeep Dhali, Umar Akram, Thai Hau Koo, Yash Shah, Fariha Hasan, Dushyant Singh Dahiya

Background

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), necessitates frequent disease monitoring to guide management. While colonoscopy remains the gold standard for assessing disease activity, its invasive nature limits its feasibility. Bowel ultrasonography (BUS) has emerged as a noninvasive alternative.

Objective

This systematic review and meta-analysis evaluate the diagnostic accuracy of BUS in detecting IBD activity compared to colonoscopy.

Methods

A comprehensive literature search of PubMed, CINAHL and Embase was conducted, including 37 studies evaluating BUS modalities such as colour Doppler, small intestine contrast ultrasonography (SICUS) and contrast-enhanced ultrasound (CEUS). Pooled sensitivity, specificity, diagnostic odds ratios (DOR) and likelihood ratios were calculated. Subgroup analyses were performed based on diagnostic modality and IBD subtype.

Results

The overall pooled sensitivity and specificity of BUS in IBD were 90.0% and 83.5%, respectively. SICUS had the highest sensitivity (95.0%), while BUS with colour Doppler had the highest specificity (85.1%). CEUS demonstrated the highest DOR (75.52). BUS performed best in detecting postoperative CD recurrence (sensitivity 91.9%, DOR 61.9). Meta-regression identified surgical anastomosis type as a significant predictor of diagnostic performance.

Conclusion

BUS is a highly effective noninvasive imaging modality for diagnosing and monitoring IBD. Its accuracy varies by modality, with SICUS optimal for screening and colour Doppler BUS for confirmation. Future studies should standardize BUS protocols and evaluate its role alongside MRI and CT enterography.

背景:炎症性肠病(IBD),包括克罗恩病(CD)和溃疡性结肠炎(UC),需要频繁的疾病监测来指导治疗。虽然结肠镜检查仍然是评估疾病活动的金标准,但其侵入性限制了其可行性。肠超声检查(BUS)已成为一种无创的替代方法。目的:本系统综述和荟萃分析比较了BUS在检测IBD活动性方面与结肠镜检查的诊断准确性。方法:综合检索PubMed、CINAHL、Embase等文献,纳入彩色多普勒、小肠对比超声(SICUS)、增强超声(CEUS)等评价BUS的37项研究。计算了合并敏感性、特异性、诊断优势比(DOR)和似然比。根据诊断方式和IBD亚型进行亚组分析。结果:BUS在IBD中的总体敏感性和特异性分别为90.0%和83.5%。SICUS的灵敏度最高(95.0%),而BUS与彩色多普勒的特异性最高(85.1%)。超声造影DOR最高(75.52)。BUS在检测术后CD复发方面表现最佳(敏感性91.9%,DOR 61.9)。meta回归确定手术吻合类型是诊断性能的重要预测因子。结论:BUS是诊断和监测IBD的一种有效的无创成像方式。其准确性因模式而异,SICUS最适合筛查,彩色多普勒BUS用于确认。未来的研究应标准化BUS方案,并评估其与MRI和CT肠造影的作用。
{"title":"Diagnostic utility of bowel ultrasonography in adults with inflammatory bowel disease: An updated systematic review and meta-analysis","authors":"Hareesha Rishab Bharadwaj,&nbsp;Syed Hasham Ali,&nbsp;Hassam Ali,&nbsp;Priyal Dalal,&nbsp;Aditya Gaur,&nbsp;Sushil Rayamajhi,&nbsp;Arkadeep Dhali,&nbsp;Umar Akram,&nbsp;Thai Hau Koo,&nbsp;Yash Shah,&nbsp;Fariha Hasan,&nbsp;Dushyant Singh Dahiya","doi":"10.1111/codi.70370","DOIUrl":"10.1111/codi.70370","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), necessitates frequent disease monitoring to guide management. While colonoscopy remains the gold standard for assessing disease activity, its invasive nature limits its feasibility. Bowel ultrasonography (BUS) has emerged as a noninvasive alternative.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This systematic review and meta-analysis evaluate the diagnostic accuracy of BUS in detecting IBD activity compared to colonoscopy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A comprehensive literature search of PubMed, CINAHL and Embase was conducted, including 37 studies evaluating BUS modalities such as colour Doppler, small intestine contrast ultrasonography (SICUS) and contrast-enhanced ultrasound (CEUS). Pooled sensitivity, specificity, diagnostic odds ratios (DOR) and likelihood ratios were calculated. Subgroup analyses were performed based on diagnostic modality and IBD subtype.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The overall pooled sensitivity and specificity of BUS in IBD were 90.0% and 83.5%, respectively. SICUS had the highest sensitivity (95.0%), while BUS with colour Doppler had the highest specificity (85.1%). CEUS demonstrated the highest DOR (75.52). BUS performed best in detecting postoperative CD recurrence (sensitivity 91.9%, DOR 61.9). Meta-regression identified surgical anastomosis type as a significant predictor of diagnostic performance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>BUS is a highly effective noninvasive imaging modality for diagnosing and monitoring IBD. Its accuracy varies by modality, with SICUS optimal for screening and colour Doppler BUS for confirmation. Future studies should standardize BUS protocols and evaluate its role alongside MRI and CT enterography.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis 前列腺癌放疗后直肠癌:倾向匹配分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-28 DOI: 10.1111/codi.70365
M. Goldenshluger, M. A. Abbas, M. Belkovsky, A. Alipouriani, K. Erozkan, G. Alon, M. A. Valente, S. R. Steele, S. D. Holubar, D. Liska, E. Gorgun
<div> <section> <h3> Aim</h3> <p>Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized.</p> <p>This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.</p> </section> <section> <h3> Methods</h3> <p>Retrospective cohort study using univariate and propensity-matched analyses.</p> <p>Data extracted from electronic medical records at a single tertiary institution [2001–2021].</p> <p>Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a <3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.</p> </section> <section> <h3> Results</h3> <p>Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (<i>p</i> < 0.001), and a higher American Society of Anaesthesiologists (ASA) score (<i>p</i> = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (<i>p</i> = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (<i>p</i> = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%–71%) and PRC (50.3%, 95% CI: 36%–64%) groups (<i>p</i> = 0.61).</p> </section> <section> <h
目的:先前接受过原发性前列腺癌(PPC)放射治疗的患者患继发性直肠癌(SRC)的风险升高。然而,在这种情况下,SRC的临床表现、手术结果和肿瘤结果仍然缺乏特征。本研究旨在比较原发性直肠癌(PRC)患者和SRC患者在前列腺癌放疗后的临床和病理特征以及治疗结果。方法:回顾性队列研究,采用单变量分析和倾向匹配分析。数据摘自单一高等教育机构的电子病历[2001-2021]。有或没有前列腺癌放疗史的男性直肠癌(RC)患者行肿瘤切除术。结果:在1755例RC患者中,50例(2.9%)发生了SRC。50名患者中的43名被纳入分析。从放疗到SRC诊断的中位时间为8±4年(IQR)。SRC患者年龄较大,平均年龄为73.7±8.5岁,对照组为61.1±13岁(p局限性:回顾性设计和对单一机构电子病历的依赖)。结论:PPC患者在放疗后10年出现SRC。SRC患者通常年龄较大,合并症较多。与PRC患者相比,接受新辅助治疗的SRC患者较少,并且作为一个群体,与PRC患者相比,需要更广泛的手术,括约肌保留率更低。尽管存在这些差异,与PRC患者相比,SRC患者具有相似的病理结果和总生存期。
{"title":"Rectal cancer following radiotherapy for prostate cancer: A propensity-matched analysis","authors":"M. Goldenshluger,&nbsp;M. A. Abbas,&nbsp;M. Belkovsky,&nbsp;A. Alipouriani,&nbsp;K. Erozkan,&nbsp;G. Alon,&nbsp;M. A. Valente,&nbsp;S. R. Steele,&nbsp;S. D. Holubar,&nbsp;D. Liska,&nbsp;E. Gorgun","doi":"10.1111/codi.70365","DOIUrl":"10.1111/codi.70365","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Aim&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized.&lt;/p&gt;\u0000 \u0000 &lt;p&gt;This study aims to compare the clinical and pathological features, as well as treatment outcomes, of patients with primary rectal cancer (PRC) and those with SRC following radiation for prostate cancer.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Retrospective cohort study using univariate and propensity-matched analyses.&lt;/p&gt;\u0000 \u0000 &lt;p&gt;Data extracted from electronic medical records at a single tertiary institution [2001–2021].&lt;/p&gt;\u0000 \u0000 &lt;p&gt;Male patients with rectal cancer (RC) who underwent oncological resection with or without a prior history of prostate cancer radiation. Patients with a &lt;3-year interval between radiotherapy and RC diagnosis were excluded. The main outcome measures were pathological analysis, postoperative complications and overall survival.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Out of 1,755 patients with RC, 50 cases (2.9%) had SRC. Forty-three out of the 50 patients were included in the analysis. The median time from radiotherapy to SRC diagnosis was 8 ± 4 years (IQR). Patients with SRC were older, with a mean age of 73.7 ± 8.5 versus 61.1 ± 13 years in the control group (&lt;i&gt;p&lt;/i&gt; &lt; 0.001), and a higher American Society of Anaesthesiologists (ASA) score (&lt;i&gt;p&lt;/i&gt; = 0.006). Most SRCs were distal with a median distance from the anal verge of 4.25 cm (IQR 9.5 cm). Only seven patients (16.3%) in the SRC group received neoadjuvant radiation therapy versus 764 (44.8%) of PRC (&lt;i&gt;p&lt;/i&gt; = 0.001). SRC patients required more extensive surgical interventions, including abdominoperineal resection (46.5% vs. 29.9%), pelvic exenteration (4.7% vs. 0.4%), and fewer sphincter-preserving procedures, including low anterior resection (48.8% vs. 68.2%) and transanal resection (0% vs. 1.5%) (&lt;i&gt;p&lt;/i&gt; = 0.02). Propensity score matching with a 1:2 ratio matching for age, body mass index (BMI), ASA score, type of surgery, and pathological staging revealed no differences between the groups regarding tumour differentiation, staging, or postoperative complications. Survival analysis at 6 years showed no significant difference in overall survival between the SRC (53.2%, 95% CI: 35%–71%) and PRC (50.3%, 95% CI: 36%–64%) groups (&lt;i&gt;p&lt;/i&gt; = 0.61).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12852529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of LGB patients undergoing colorectal cancer surgery: A focus on sexuality 结直肠癌手术中LGB患者的经验:对性的关注。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-28 DOI: 10.1111/codi.70375
Anna Provoost, Louis Onghena, Khushi Jeswani, Yves van Nieuwenhove, Eva Pape, Gabrielle H. van Ramshorst

Purpose

This study aimed to delineate the existing knowledge regarding the impact of colorectal cancer surgery on the sexuality of LGB patients, highlighting the need for culturally competent care tailored to their unique needs.

Methods

A comprehensive search was conducted from October 2024 onwards across PubMed, Embase, CINAHL, Google Scholar, Web of Science, Scopus, PsychINFO, Cochrane Library, and Joanna Briggs Institute using the MeSH terms ‘sexual and gender minorities’, ‘colorectal surgery’, ‘colorectal neoplasms’ and ‘sexuality’. Inclusion criteria required LGB patients over 18 years, at least 50% of the sample diagnosed with colorectal cancer and treated operatively. All studies were critically appraised.

Results

Six studies from the UK and the US were included. Sample size ranged from 1 to 480. Participants identifying as LGB ranged from 26.4 to 100%. Key findings revealed LGB patients experience similar physical consequences to heterosexual patients (erectile and ejaculatory dysfunction, dyspareunia, vaginal dryness), but implications might differ, e.g., regarding anal intercourse. A lower mental quality of life was reported, including body image issues related to stomas. Relationship challenges and intimacy issues were highlighted. The cultural competence of healthcare providers has a significant influence on patient experiences, highlighting a gap in inclusive care. Critical appraisal revealed both methodological strengths and weaknesses.

Conclusion

This review highlighted the sexual health challenges of LGB patients after colorectal cancer surgery, with issues like sexual function and mental wellbeing often being underreported. Cultural competence training for healthcare providers and integrating patients' partners into cancer care are crucial for a holistic approach.

目的:本研究旨在描述关于结直肠癌手术对LGB患者性取向影响的现有知识,强调需要针对他们的独特需求量身定制具有文化能力的护理。方法:从2024年10月起在PubMed、Embase、CINAHL、b谷歌Scholar、Web of Science、Scopus、PsychINFO、Cochrane Library和Joanna Briggs Institute进行全面检索,使用MeSH术语“性和性别少数群体”、“结直肠外科”、“结直肠肿瘤”和“性”。纳入标准要求18岁以上的LGB患者,至少50%的样本被诊断为结直肠癌并接受手术治疗。所有的研究都经过严格的评价。结果:纳入了来自英国和美国的6项研究。样本量从1到480。认同为LGB的参与者从26.4%到100%不等。主要研究结果显示,LGB患者与异性恋患者经历相似的生理后果(勃起和射精功能障碍、性交困难、阴道干燥),但含义可能有所不同,例如,在肛交方面。据报道,精神生活质量较低,包括与气孔有关的身体形象问题。强调了关系挑战和亲密问题。医疗保健提供者的文化能力对患者体验有重大影响,突出了包容性护理的差距。批判性评价揭示了方法论的优点和缺点。结论:本综述强调了结直肠癌手术后LGB患者的性健康挑战,性功能和心理健康等问题往往被低估。对医疗保健提供者进行文化能力培训,并将患者的合作伙伴纳入癌症护理中,这对整体方法至关重要。
{"title":"Experiences of LGB patients undergoing colorectal cancer surgery: A focus on sexuality","authors":"Anna Provoost,&nbsp;Louis Onghena,&nbsp;Khushi Jeswani,&nbsp;Yves van Nieuwenhove,&nbsp;Eva Pape,&nbsp;Gabrielle H. van Ramshorst","doi":"10.1111/codi.70375","DOIUrl":"10.1111/codi.70375","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>This study aimed to delineate the existing knowledge regarding the impact of colorectal cancer surgery on the sexuality of LGB patients, highlighting the need for culturally competent care tailored to their unique needs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A comprehensive search was conducted from October 2024 onwards across PubMed, Embase, CINAHL, Google Scholar, Web of Science, Scopus, PsychINFO, Cochrane Library, and Joanna Briggs Institute using the MeSH terms ‘sexual and gender minorities’, ‘colorectal surgery’, ‘colorectal neoplasms’ and ‘sexuality’. Inclusion criteria required LGB patients over 18 years, at least 50% of the sample diagnosed with colorectal cancer and treated operatively. All studies were critically appraised.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Six studies from the UK and the US were included. Sample size ranged from 1 to 480. Participants identifying as LGB ranged from 26.4 to 100%. Key findings revealed LGB patients experience similar physical consequences to heterosexual patients (erectile and ejaculatory dysfunction, dyspareunia, vaginal dryness), but implications might differ, e.g., regarding anal intercourse. A lower mental quality of life was reported, including body image issues related to stomas. Relationship challenges and intimacy issues were highlighted. The cultural competence of healthcare providers has a significant influence on patient experiences, highlighting a gap in inclusive care. Critical appraisal revealed both methodological strengths and weaknesses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This review highlighted the sexual health challenges of LGB patients after colorectal cancer surgery, with issues like sexual function and mental wellbeing often being underreported. Cultural competence training for healthcare providers and integrating patients' partners into cancer care are crucial for a holistic approach.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A stepped nurse-led LARS clinic: A qualitative evaluation 阶梯式护士主导的LARS诊所:定性评价。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-27 DOI: 10.1111/codi.70379
Noa Bornauw, Gabriëlle H. van Ramshorst, Yves Van Nieuwenhove, Dirk Van de Putte, Kjell Fierens, Paul Pattyn, Karen Geboes, Ann Van Hecke, Eva Pape

Aim

This study aimed to evaluate the significance of a stepped nurse-led low anterior resection syndrome (LARS) clinic for patients.

Methods

A Nurse-Led Clinic (NLC) with a stepped intervention approach for patients with LARS was developed and implemented. An exploratory study was conducted in three hospitals to evaluate the nurse-led clinic. Adult rectal cancer patients experiencing LARS who attended the NLC were recruited via maximum variation sampling for semi-structured interviews. Thematic analysis was performed, employing researcher triangulation to enhance reliability.

Results

Seventeen participants were interviewed to evaluate the clinic. Participants described five characteristics: (1) presence of the nurse, (2) accessibility, (3) providing recognition, affirmation and understanding, (4) coordinating and (5) timing of the consultation. In addition, participants outlined four principal tasks: (1) providing information, (2) management of symptoms, (3) support and (4) follow-up and continuity of care.

Conclusion

The NLC offered meaningful support by addressing patients' concerns comprehensively. It normalised the condition, empowered patients with tailored information and provided effective symptom management strategies.

Reporting Method

SRQR checklist.

目的:本研究旨在评价阶梯式护士引导下下前切除术综合征(LARS)门诊对患者的意义。方法:建立护士主导诊所(NLC),对LARS患者进行阶梯式干预。在三家医院进行了一项探索性研究,以评估护士主导的诊所。参加NLC的经历LARS的成年直肠癌患者通过最大变异抽样进行半结构化访谈。采用研究者三角法进行专题分析,以提高可靠性。结果:对17名参试者进行访谈评价。参与者描述了五个特征:(1)护士在场;(2)无障碍;(3)提供认可、肯定和理解;(4)协调和(5)咨询的时机。此外,与会者概述了四项主要任务:(1)提供信息;(2)管理症状;(3)支持;(4)跟踪和持续护理。结论:NLC全面解决了患者的担忧,提供了有意义的支持。它使病情正常化,为患者提供量身定制的信息,并提供有效的症状管理策略。报告方法:SRQR清单。
{"title":"A stepped nurse-led LARS clinic: A qualitative evaluation","authors":"Noa Bornauw,&nbsp;Gabriëlle H. van Ramshorst,&nbsp;Yves Van Nieuwenhove,&nbsp;Dirk Van de Putte,&nbsp;Kjell Fierens,&nbsp;Paul Pattyn,&nbsp;Karen Geboes,&nbsp;Ann Van Hecke,&nbsp;Eva Pape","doi":"10.1111/codi.70379","DOIUrl":"10.1111/codi.70379","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study aimed to evaluate the significance of a stepped nurse-led low anterior resection syndrome (LARS) clinic for patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A Nurse-Led Clinic (NLC) with a stepped intervention approach for patients with LARS was developed and implemented. An exploratory study was conducted in three hospitals to evaluate the nurse-led clinic. Adult rectal cancer patients experiencing LARS who attended the NLC were recruited via maximum variation sampling for semi-structured interviews. Thematic analysis was performed, employing researcher triangulation to enhance reliability.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Seventeen participants were interviewed to evaluate the clinic. Participants described five characteristics: (1) presence of the nurse, (2) accessibility, (3) providing recognition, affirmation and understanding, (4) coordinating and (5) timing of the consultation. In addition, participants outlined four principal tasks: (1) providing information, (2) management of symptoms, (3) support and (4) follow-up and continuity of care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The NLC offered meaningful support by addressing patients' concerns comprehensively. It normalised the condition, empowered patients with tailored information and provided effective symptom management strategies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Reporting Method</h3>\u0000 \u0000 <p>SRQR checklist.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colorectal Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1